1Arguinzoniz M, Duerr Myers L, Engrand P, et al. The efficacy and safety of recombinant human luteinizing hormone for minimizing the number of pre-ovulatory follicles in WHO group I anovulatory women treated with rhFSH[C]. Program of the 15th Annual Meetin 被引量：1
2Loumaye E, Duerr-Myers L, Engrand P, et al. Minimizing the number of pre-ovulatory follicles in WHO group II anovulatory women over-responding to FSH with recombinant human luteinizing hormone[C]. Program of the 15th Annual Meeting of the European Society 被引量：1
3Felberbaum R, Diedrich K. Ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin releasing hormone analogues: agonists and antagonists[J]. Hum Reprod, 1999, 14[Suppl 1]:207-221. 被引量：1
4Borm GF, Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, mul 被引量：1
5Hsieh Y, Tsai H, Chang C, et al. Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analog (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program[J]. Fertil S 被引量：1
6Christin Maitre S, Olivennes F, Dubourdieu S, et al. Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation[J]. Clin Endocrinol (Oxf), 2000, 52(6): 721-726. 被引量：1
7Posada MN, Vlahos NP, Jurema MW, et al. Clinical outcome of using ganirelix acetate versus a 4-day follicular phase leuprolide acetate protocol in unselected women undergoing in vitro fertilization[J]. Fertil Steril, 2003, 80(1): 103-110. 被引量：1
8Khalaf Y, El-Toukhy T, Taylor A, et al. Increasing the gonadotrophin dose in the course of an in vitro fertilization cycle does not rectify an initial poor response[J]. Eur J Obstet Gynecol Reprod Biol, 2002, 103(2): 146-149. 被引量：1
9Wang PT, Lee RK, Su JT, et al. Cessation of low-dose gonadotropin releasing hormone agonist therapy followed by high-dose gonadotropin stimulation yields a favorable ovarian response in poor responders[J]. J Assist Reprod Genet, 2002, 19(1): 1-6. 被引量：1
10Elkind-Hirsch KE, Webster BW, Brown CP, et al. Concurrent ganirelix and follitropin beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome[J]. Fertil Steril, 2003, 79(3): 603-607. 被引量：1
同被引文献10
1Biljan MM, Mahutte NG, Dean N, et al. Pretreatmaent with an oral contraceptive is effective in reducing the incidence of functional ovarian stcyformation during pituitary suppression bygonadotropin releasing hormone analogues. Assist Reprod Genet, 1998, 15(10): 599-601. 被引量：1
2Biljan MM, Mahutte NG, Dean N. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin releasing hormone analogues and on subsequent implanta-tion and pregnancy rates. Fertil Steril, 1998,70(6): 1063-4. 被引量：1
3Damario MA, Barmat L, Liu HC et cd. Dual suppression with oral contraceptives and gonadotrophin releasing - hormone agonists improves in -vitro fertilization outcome in high responder patients Hum Reprod, 1997, 12 (11): 2359 被引量：1
5Biljan MM, Mahutte NG, Dean N et al. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian stcyforrnation during pituitary suppression bygonadotropin - releasing hormone analogues. Assist Reprod C, enet, 1998, 15 (10) : 599 被引量：1
6Biljan MM, Mahutte NG, Dean N, Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin - releasing hormone analogues and on subsequent implantation and preguancy rates. Fertil Steril, 1998, 70 (6) : 1063 被引量：1
